ICAR IVRI Annual Review Meeting 2024-25 Vaccines Diagnostics Bengaluru Highlights

ICAR IVRI Bengaluru hosts the 2024-25 annual review meeting of CRP on Vaccines and Diagnostics, unveiling innovations, patents, and new genome editing projects.

Introduction: Fostering Innovation in Animal Health Research

The ICAR IVRI annual review meeting 2024-25 vaccines diagnostics Bengaluru showcased India’s commitment to advancing scientific research in animal health, fisheries, and livestock development. Organized at the ICAR-Indian Veterinary Research Institute (IVRI) Bengaluru campus from October 23–24, 2025, the two-day event highlighted the major achievements of the Consortium Research Platform (CRP) on Vaccines and Diagnostics for the 2024–25 period.

Under the aegis of the Indian Council of Agricultural Research (ICAR), the meeting served as a convergence of innovation, collaboration, and foresight in the fields of veterinary and agricultural science. Key stakeholders, researchers, and scientists from 14 premier ICAR institutes participated, reviewing 31 ongoing projects aimed at improving animal health and enhancing the livelihoods of farmers.

ICAR Leadership’s Vision for Research and Innovation

In his inaugural address, Dr. Raghavendra Bhatta, Deputy Director General (Animal Sciences), ICAR, emphasized the intersectoral approach of CRP on Vaccines and Diagnostics, which integrates the Animal Sciences, Fisheries, and Livestock subsectors. He praised the CRP’s success in developing innovative technologies that have directly benefited farmers and entrepreneurs engaged in animal husbandry.

Dr. Bhatta stressed that the next phase of research must focus on non-bovine milk sources, particularly camel and goat milk, to meet the increasing nutritional demands of diverse communities. He further encouraged scientists to explore Genome Editing, Cloning, and the ‘One Health’ approach that aligns animal, human, and environmental health research.

He highlighted that industry partnerships will play a key role in commercializing newly developed technologies, ensuring that scientific innovations reach end users effectively. Such collaborations, he noted, will strengthen India’s position in global animal biotechnology research and boost rural livelihoods.

Strategic Overview of the CRP on Vaccines and Diagnostics

Dr. Pallab Chaudhuri, Joint Director of ICAR-IVRI Bengaluru campus and Project Coordinator of CRP on V&D, presented a detailed review of the platform’s progress during the 2024-25 period. He reported that three new technologies were released, eight were commercialized, and seven patents were filed, reflecting the CRP’s expanding contribution to India’s biotechnology ecosystem.

The CRP on Vaccines & Diagnostics industry partnership non-bovine milk research model has been instrumental in aligning research outputs with industrial demands. The emphasis on translational research—transforming laboratory innovations into market-ready solutions—was recognized as a key driver of the program’s success.

Insights from Participating Experts

Distinguished scientists including Dr. Divakar Hemadri (ADG, Animal Health), Dr. Shubhadeep Ghosh (ADG, Marine Fisheries), Dr. Bikash Mandal (ADG, International Relations), and Dr. S.K. Singh (Joint Director, Research, ICAR-IVRI) contributed valuable suggestions to strengthen ongoing projects.

Their collective focus revolved around expanding interdisciplinary collaboration, streamlining project management, and increasing resource utilization efficiency. The one health canine health genome editing livestock research ICAR IVRI agenda was also discussed as an emerging area that bridges genomics, biosecurity, and sustainable veterinary practices.

Sectoral Achievements and Collaborative Synergies

Each sector within the CRP platform shared key progress updates:

• Dr. B.P. Sreenivasa (Livestock Sector Coordinator) highlighted advances in animal vaccine research and disease diagnostics.
• Dr. R. Selvarajan (Director, ICAR-NRCB, Agriculture Sector Coordinator) shared updates on crop-related disease detection tools, enhancing agricultural resilience.
• Dr. M. Makesh (Fisheries Sector Coordinator) detailed innovations in aquatic diagnostics, supporting India’s expanding blue economy.

These presentations underscored the importance of cross-sector collaboration and demand-driven research. It was resolved that future research initiatives would prioritize projects aligned with the next Expenditure Finance Committee (EFC) framework.

Expanding Research Horizons through Advanced Technologies

A major decision during the meeting was to conduct a hands-on workshop on CRISPR-based diagnostics at CIFE Mumbai for CRP scientists. This initiative reflects India’s growing commitment to leveraging gene-editing tools for accurate disease detection and management.

The CRISPR based diagnostics workshop CRP V&D Mumbai demand-driven research program aims to enhance the diagnostic capabilities of scientists and promote collaborative learning across research institutions. Such skill-building efforts will accelerate the adoption of cutting-edge biotechnological tools in veterinary sciences.

Commercialization and Intellectual Property Achievements

During the review, it was revealed that multiple technologies developed under CRP have moved beyond the research stage to commercial deployment. The ICAR IVRI Bengaluru release commercialise technologies patents filed 2024-25 milestone stands as a testament to India’s ability to translate research into tangible products and services.

Commercialization ensures that innovations do not remain confined to laboratories but are effectively transferred to industries and farmers. The filing of seven patents marks a significant step toward protecting intellectual property while encouraging innovation in public-funded research.

Strengthening India’s ‘One Health’ Framework

The One Health approach—linking animal, human, and environmental health—is emerging as a cornerstone of ICAR’s future strategy. Experts at the meeting discussed integrating livestock disease surveillance, zoonotic disease research, and environmental monitoring to build a resilient healthcare ecosystem.

India’s focus on One Health canine and livestock research aligns with the global Sustainable Development Goals (SDGs), particularly those related to health, innovation, and sustainability.

Empowering the Next Generation of Scientists

The CRP on Vaccines and Diagnostics has also been pivotal in mentoring young researchers. The annual review meeting emphasized capacity building, encouraging emerging scientists to take leadership roles in bioinformatics, molecular diagnostics, and pathogen genomics.

Dr. Chaudhuri noted that several young investigators are working on genome editing and non-bovine milk research, contributing to nutritional diversification and sustainable farming systems.

Expert Commentary: India’s Rising Biotech Momentum

According to Dr. Anil Sharma, a biotechnology policy expert and former member of the Biotech Consortium India Limited (BCIL), India’s proactive research models such as CRP on V&D showcase “a perfect blend of scientific excellence and social responsibility.” He observed that ICAR IVRI’s Bengaluru initiative sets a national benchmark for interdisciplinary and industry-oriented veterinary research.

Dr. Sharma further stated, “The future of Indian veterinary biotechnology lies in our ability to combine innovation with accessibility. The progress shown by CRP on Vaccines and Diagnostics is an example of how research can transform rural livelihoods.”

Future Outlook: Towards Sustainable Animal Health Solutions

As the ICAR IVRI moves ahead with its ambitious roadmap for 2025–26, emphasis will remain on scalable technologies, public-private partnerships, and farmer-centric models. The integration of CRISPR, genome editing, and smart diagnostics will redefine how animal diseases are detected and controlled in India.

The event also underscored the importance of continuous stakeholder engagement, policy support, and funding to ensure that India maintains its leadership in veterinary research.

For students and professionals seeking deeper insights into animal science, related NCERT courses, notes, current affairs, MCQs, and videos on allied subjects can be accessed for continued learning.

Institutions and schools looking to strengthen their online presence can explore Mart India Infotech for customized educational website solutions.

Conclusion

The ICAR IVRI annual review meeting 2024-25 vaccines diagnostics Bengaluru reaffirmed India’s vision of integrating science, innovation, and sustainability in animal health research. With an emphasis on cross-disciplinary collaboration, intellectual property creation, and technology transfer, the CRP on Vaccines and Diagnostics continues to propel the country toward a more secure and sustainable future in veterinary biotechnology.

Purchase Today

Frequently Asked Questions (FAQs)

Q1. What was the main objective of the ICAR IVRI annual review meeting 2024-25 vaccines diagnostics Bengaluru?
A1. The meeting aimed to evaluate progress under the CRP on Vaccines and Diagnostics and outline research priorities for 2025–26.

Q2. Who inaugurated the ICAR IVRI Bengaluru annual review meeting?
A2. Dr. Raghavendra Bhatta, Deputy Director General (Animal Sciences), ICAR, inaugurated the event.

Q3. How many technologies were released during 2024–25 under CRP on Vaccines and Diagnostics?
A3. Three technologies were released, eight commercialized, and seven patents filed.

Q4. What new research areas were proposed during the review meeting?
A4. Focus areas included non-bovine milk research, cloning, genome editing, and One Health.

Q5. Which sectors were part of the CRP on Vaccines and Diagnostics?
A5. Animal sciences, fisheries, and agriculture crop science sectors participated.

Q6. What is the role of industry partnerships in CRP research?
A6. Industry collaborations help commercialize innovations and improve farmer access to new technologies.

Q7. Where will the CRISPR-based diagnostics workshop be held?
A7. The workshop will be organized at CIFE Mumbai for CRP scientists.

Q8. How does CRP contribute to India’s One Health initiative?
A8. By integrating animal, human, and environmental health research for sustainable solutions.

Q9. Which ICAR officials provided expert insights during the meeting?
A9. Dr. Divakar Hemadri, Dr. Shubhadeep Ghosh, Dr. Bikash Mandal, and Dr. S.K. Singh.

Q10. How does ICAR IVRI’s Bengaluru campus support young scientists?
A10. Through mentorship, workshops, and research opportunities in biotechnology and diagnostics.